The data presented here demonstrate that the pathogenicity of oral Candida isolates is similar to systemic Candida isolates, suggesting that the pathogenicity of Candida is not correlated with the infected site. The pathogenesis of both oral and systemic candidiasis is closely dictated by properties of the yeast GANT61 cell line biofilms [28, 29]. Implanted devices, such as venous catheters or dental prosthesis, are a serious risk factor for Candida infections. They are substrates for the

formation of biofilm, which in turn serve as reservoirs of cells to continually seed an infection [8]. It has been estimated that at least 65% of all human infectious are related to microbial biofilms [30, 31]. A variety of click here methods have recently been used for the quantification of Candida biofilm on different substrata. These include counting of colony forming units (CFU), dry-weight assays, spectrophotometric analysis, and colorimetric assays, such as 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide

(XTT) reduction assay. However, each method carries its own advantages and limitations [7, 32, 33]. In our study, we used a dry-weight assay because this method allows the single quantification of a Candida biofilm on a clinically relevant substrate such as silicone and acrylic resin. Silicone is frequently Telomerase used in the manufacture of medical devices and catheters and it is related to development of systemic candidiasis in hospitalized patients. Acrylic resin (methyl methacrylate) is a material widely used in preparation of dental prosthesis and it has significance for development of oral candidiasis.

Among all isolates tested in this study, the quantity of biofilm mass varied according to the Candida species. C. albicans and C. dubliniensis were the highest biofilm producers on silicone pads, followed by C. tropicalis, C. norvegensis, C. parapsilosis, C. glabrata, C. krusei, C. lusitaniae, and C. kefyr. Most studies have shown that the biofilm formation by clinical isolates of Candida was species dependent and generally the highest levels of biofilm formation were observed in C. albicans and the lowest in C. glabrata [5, 20]. Notably, unlike C. albicans and other Candida species, C. glabrata is unable to generate filamentous forms which may contribute to the impared ability of C. glabrata to form a biofilm [5]. The observations for higher quantities of biofilm Rabusertib production by C. albicans and lower biofilm production from the non filamenting C. glabrata, given the same standards of in vitro test conditions, remained true for the clinical isolates from our study. Indeed, for both strains collected orally or systemically, there was very little in the way of quantity or quality of biofilm production for C. glabrata. C.